Functional Biomarkers of Platinum Chemotherapy and PARP Inhibitor Response

by | Jan 19, 2024 | Lomonosova, Elena, Mullen, Mary, Verma, Priyanka, Zhao, Peinan

— T-020659 — Functional Biomarkers of Platinum Chemotherapy and PARP Inhibitor Response

Technology Description

Most patients diagnosed with high-grade serous ovarian cancer (HGSOC) undergo first-line platinum therapy and PARP inhibitor maintenance therapy. However, the degree to which HGSOC p…